Your browser doesn't support javascript.
loading
Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma.
Kim, Kyoung Ha; Kim, Won Seog; Kim, Seok Jin; Yoon, Dok Hyun; Suh, Cheolwon; Kang, Hye Jin; Choi, Chul Won; Lee, Ho Sup; Bae, Sung Hwa; Park, Jinny; Park, Eun Kyung; Kwak, Jae-Yong; Lee, Mark Hong; Kang, Byung Woog; Park, Sung-Kyu; Won, Jong-Ho.
Afiliação
  • Kim KH; Division of Hematology & Oncology, Department of Internal Medicine, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Korea.
  • Kim WS; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim SJ; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Suh C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kang HJ; Division of Hematology-Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Science, Seoul, Korea.
  • Choi CW; Division of Oncology-Hematology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Lee HS; Division of Hematology/Oncology, Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, Korea.
  • Bae SH; Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea.
  • Park J; Division of Hematology, Deparment of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • Park EK; Division of Hematology/Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Kwak JY; Division of Hematology/Oncology, Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea.
  • Lee MH; Division of Hematology-Oncology, Department of Internal Medicine, Konkuk University School of Medicine, Konkuk University, Seoul, Korea.
  • Kang BW; Department Hematology/Oncology, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Daegu, Korea.
  • Park SK; Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon-Si, Gyeonggi-Do, Korea.
  • Won JH; Division of Hematology & Oncology, Department of Internal Medicine, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Korea.
Transpl Int ; 33(10): 1211-1219, 2020 10.
Article em En | MEDLINE | ID: mdl-32479690

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Transplante de Células-Tronco Hematopoéticas / Linfoma País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Transplante de Células-Tronco Hematopoéticas / Linfoma País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article